4 Followers USX:VERU - Veru Inc Veru Inc
Sector: Consumer Staples, Industry: Personal Products
Next Earnings: 7 Dec 2021
Add to Watchlist
Add Alert 

Yahoo Finance

USD 9.07    -0.180 (-1.95%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

24 Sep 2021



CEO: Dr. Mitchell S. Steiner F.A.C.S., M.D., F.A.C.S

IPO: 1990-07-19

Headquarters: US

Employees: 339



Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.